We can’t believe a whole year has passed here at Lavaa. Needless to say, all of us on the team have passed right through this milestone, full engines ahead, towards our 2nd exciting year.
We are happy to announce that Lavaa’s proprietary Atrial Fibrillation and Coronary Artery Disease health modules are up and running.
These health modules indicate the risk for deterioration and can prevent unnecessary hospitalizations. According to the CDC, A Fib. alone causes over 454,000 hospitalizations every year in the US. Using Lavaa’s health modules with our Personalized Preemptive Program (TM) will be a powerful aid in reducing hospitalizations worldwide.
In other news, we would like to share with you that all three interns from the Onward Israel program, which took place last summer, have decided to continue and join Lavaa! We want to give a warm welcome to Dahlia Moskowitz, Maya Hollander, and Eliana Moskowitz from the whole team here at Lavaa. They will be part of the Lavaa journey as interns/Junior Research Analysts, members of the research and medical teams.
Finally, Our founders will be attending and showcasing Lavaa at the upcoming HTLH conference!
HLTH is considered as the leading event aimed at bringing together the entire health innovation ecosystem. With over 350 speakers, 9,500 participants, and already scheduled meetings for Lavaa team, this is the place to be! We will keep you updated, so stay tuned!
We welcome and encourage you to request a demo of the LAVAA platform here